AVID BIOSERVICES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.295 USD | +11.72% |
|
+23.35% | +43.85% |
| 07-02 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
| 07-02 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 529M | - | - | - | |||
| 101B | ||||||
| 42.18B | ||||||
| 32.26B | ||||||
| 29.79B | ||||||
| 16.06B |
